Sort by
Refine Your Search
-
underrepresented groups in science to apply. Position Type Research Additional Information Northeastern University considers factors such as candidate work experience, education and skills when extending an offer
-
. graduates in various areas of industry pharmacy including regulatory affairs, medical information/affairs, patient safety, outcomes research, and many other areas. The program is a collaboration between
-
Disorder is a collaboration between CDD training faculty based in the Departments of Pharmaceutical Sciences and Chemistry and Chemical Biology at Northeastern University in Boston, MA (Drs. Raymond Booth
-
will be, too. But don’t just take our word for it – learn more about life at Arvinas and what employees have to say . For more information, please visit www.arvinas.com . Responsibilities: Global
-
Group, including Medical Excellence, Medical Strategy, Patient Affairs, Medical Information, Health Economics, Medical Operations, and Patient Safety Participate in MSL trainings to accompany MSL on field
-
diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause
-
initiative on a variety of projects at the industry site and Northeastern. Additional Information: Applicants should submit the following APPLICATION MATERIALS: Curriculum vitae (CV), uploaded Unofficial
-
, Department of Pharmacy & Health System Sciences Director of Pharmaceutical Industry Fellowship Program 360 Huntington Ave, 140TF R218 Boston, MA 02115 Position Type Research Additional Information Northeastern
-
opportunity to work collaboratively with other functional areas within Ironwood including clinical development, medical scientific affairs, program management, data sciences, quality and compliance, nonclinical
-
generation. In both functions, the fellow will have the opportunity to work collaboratively with the other functional areas within Ironwood including regulatory, global patient safety, commercial, data